close

Nirmal, G.R., Liao, C.C., Lin, Z.C., Alshetaili, A., Hwang, E., Yang, S.C., Fang, J.Y. (2023) Topically applied pH-responsive nanogels for alkyl radical-based therapy against psoriasiform hyperplasia. Drug. Deliv., 30, 2245169.

Tsai, M.J., Lin, C.Y., Trousil, J., Sung, C.T., Lee, M.H., Fang, J.Y., Yang, S.C. (2023) Proteinase K/retinoic acid-loaded cationic liposomes as multifunctional anti-acne therapy to disorganize biofilm and regulate keratinocyte proliferation. Int. J. Nanomed., 18, 3879‒3896.

Chang, Y.T., Huang, T.H., Alalaiwe, A., Hwang, E., Fang, J.Y. (2023) Small interfering RNA-based nanotherapeutics for treating skin-related diseases. Expert Opin. Drug Deliv., 20, 757‒772.

Yang, S.C., Lin, C.F., Alshetaili, A., Aljuffalin, I.A., Chien, M.Y., Fang, J.Y.* (2023) Dual antibacterial and regenerative activities of platelet-rich plasma combined with β-lactam antibiotics are effective to treat MRSA-infected skin wound: the cell- and animal-based studies. Biomed. Pharmacother., 165, 115017.

Huang, T.H., Chen, C.J., Lin, H.C.A., Chen, C.H., Fang, J.Y. (2023) Self-nanoemulsifying drug delivery system-containing the poorly absorbed drug‒valsartan in post-bariatric surgery. Int. J. Nanomed., 18, 2647‒2658.

Chang, Z.Y., Chen, C.W., Tsai, M.J., Chen, C.C., Alshetaili, A., Hsiao, Y.T., Fang, J.Y. (2023) The elucidation of structure-activity and structure-permeation relationships for the cutaneous delivery of phytosterols to attenuate psoriasiform inflammation. Int. Immunopharmacol., 119, 110202.

Lin, C.Y., Yu, H.P., Chang, Y.T., Lin, Z.C., Alalaiwe, A., Hwang, T.L., Fang, J.Y. (2023) Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation. Biomater. Sci., 11, 873–893.

Lin, Z.C., Hsu, C.Y., Hwang, E., Wang, P.W., Fang, J.Y. (2023) The role of cytokines/chemokines in aging skin immune microenvironment. Mech. Ageing Dev., 210, 111761.

arrow
arrow
    全站熱搜

    Pharmaceutics 發表在 痞客邦 留言(0) 人氣()